Multifunctional nanocomplex designed for enhanced cell uptake, endosomal escape and improved cancer therapeutic effect

Patrick Almeida

University of Helsinki

Patrick Almeida is a pharmacy major and currently a PhD student at the Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Finland. He started his doctoral studies after obtaining his Master’s Degree in Pharmaceutical Sciences from the Faculty of Pharmacy, University of Coimbra, Portugal, in July 2012. During his PhD studies, he has been mainly focused on developing porous silicon-based multifunctional nanocomposites for cancer targeting, drug delivery and theranostic applications, and has co-authored twelve scientific publications. Recently, Patrick Almeida has been working as a visiting PhD student at the German Cancer Research Center, in Heidelberg, Germany. 


Introduction Over the past few decades, breakthroughs in nanotechnology have paved the way for a new era of cancer theranostics.[1] Porous silicon (PSi) nanoparticles have demonstrated tremendous potential for drug delivery... [ view full abstract ]


  1. Patrick Almeida (University of Helsinki)
  2. Mohammad-Ali Shahbazi (Technical University of Denmark)
  3. Alexandra Correia (University of Helsinki)
  4. Ermei Mäkilä (University of Turku)
  5. Marianna Kemell (University of Helsinki)
  6. Jarno Salonen (University of Turku)
  7. Jouni Hirvonen (University of Helsinki)
  8. Hélder Santos (University of Helsinki)

Topic Areas

Targeted drug delivery and nanocarriers , Nanomedicine for cancer diagnosis & therapy


OS1b-207 » Nanomedicine for cancer diagnosis & therapy (16:20 - Monday, 25th September, Room 207)

Presentation Files

The presenter has not uploaded any presentation files.